New combo therapy aims to shrink liver tumors in advanced colon cancer
NCT ID NCT07082439
Summary
This study is testing whether combining two drugs, pembrolizumab and odetiglucan, is safe and can help shrink tumors in people with colorectal cancer that has spread mainly to the liver. It is for patients whose cancer has continued to grow despite trying standard treatments. The main goal is to see how many people's tumors shrink significantly or disappear.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA METASTATIC IN THE LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Abramson Cancer Center at the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.